Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash flows from operating activities          
Net income (loss) $ 968 $ (3,978) $ 20,907 $ (4,316)  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Realized loss on marketable debt securities     192 40  
Depreciation and amortization     3,792 2,044  
Amortization of debt discount     4 4  
Amortization on operating lease right-of-use assets     254 247  
Loss on sale of assets     14  
Stock-based compensation expense     2,979 2,438  
Change in fair value of investment securities 265 76 101  
Accounts receivable allowances     2,528  
Inventory valuation reserve     (179)  
Non-cash interest income on secured promissory note receivable     (315)  
Changes in operating assets and liabilities:          
Accounts receivable     (2,652) (7,327)  
Inventory     (133) (5,036)  
Prepaid expenses and other current assets     643 1,639  
Deferred tax asset     (1,339)  
Other assets     (674) (368)  
Accounts payable     (5,483) (1,749)  
Accrued diagnostic services     (1,616) 3,260  
Accrued advertising and other allowances     (25)  
Deferred revenue     946 1,461  
Operating lease liabilities     (223) 197  
Income tax payable     7,029  
Other current liabilities     700 (1,292)  
Net cash provided by (used in) operating activities     27,740 (8,972)  
Cash flows from investing activities          
Business acquisitions, net of cash acquired     (9,066)  
Issuance of secured promissory note receivable     (1,000)  
Purchase of marketable securities     (1,003) (21,527)  
Proceeds from sale of marketable debt securities     5,800 10,701  
Proceeds from dispositions of property and other assets, net     452  
Capital expenditures     (2,323) (4,258)  
Net cash provided by (used in) investing activities     2,926 (25,150)  
Cash flows from financing activities          
Proceeds from issuance of common stock from public offering, net     35,135  
Proceeds from issuance of common stock and warrants from private offering     5,500  
Repayment of note payable     (1,444)  
Repurchases of common shares     (1,200)  
Payment of dividends     (9,351) (4,546)  
Repurchase of common stock for payment of statutory taxes due on cashless exercise of stock option     (4,530)  
Net cash (used in) provided by financing activities     (16,525) 36,089  
Increase in cash, cash equivalents and restricted cash     14,141 1,967  
Cash, cash equivalents and restricted cash, at the beginning of the period     8,658 6,816 $ 6,816
Cash, cash equivalents and restricted cash, at the end of the period $ 22,799 $ 8,783 22,799 8,783 $ 8,658
Supplemental disclosures:          
Cash paid for income taxes     1,500  
Interest payment on the promissory notes     631 750  
Supplemental disclosure of non-cash investing and financing activities:          
Issuance of common shares for debt conversion     600 3,608  
Net unrealized loss, investments in marketable debt securities     $ (113) $ (111)